IPSEY – ipsen sa s/adr (US:NASDAQ)

News

Origami Therapeutics Announces Global Collaboration with Ipsen to Advance Protein Degrader Program
Ipsen nominates Peter Guenter to its Board of Directors
Pierrick Lefranc appointed as Executive Vice President Technical Operations, member of Executive Leadership Team
Arbitration tribunal upholds Ipsen’s termination of R&D agreement with Galderma
U.S. FDA grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in first line unfit Acute Myeloid Leukemia
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com